This edition of Microbiology Australia is dedicated to the issue of emerging technology in diagnostics and its suitability to the response to emerging animal and human disease. It is fittingly entitled 'Diagnostics into the future'. There is valid argument that the current pattern of infectious diseases is not historically unprecedented 1 and has major driving forces of human population translocation, transhumance, exposure of naïve populations, increasing contact with wildlife and intensive agriculture [1] [2] [3] [4] investigation.
An interesting example of this is the emergence of cryptococcosis in
Canada over the past 15 years or so 5, 6 . Not a new disease, crypto- PCR technology is now commonly used for many diagnostic and research applications. However, the ability to quantify microbial loads using conventional PCR still has significant limitations. Kerry Emslie, from the National Measurement Institute, introduces another method of quantification using digital PCR, which is gaining increasing utility through advances in microfluidic technology.
Digital PCR is now providing accuracy of quantification and high reproducibility, and is likely to replace traditional PCR in many settings in the near future.
Deciphering DNA sequences is essential for virtually all branches of microbial research. A significant step in our ability to do so efficiently and cost-effectively was the development of capillary electropho- 
